Beckman Coulter Diagnostics actively supports laboratories by focusing on the development of innovative assays and enhancing laboratory preparedness for future threats from infectious diseases. The company’s expertise in infectious diseases is global, thanks to sites in Ireland, France, the United States, and Israel.
This year, at EuroMedLab 2025, held in Brussels from 18-22 May, Beckman Coulter Diagnostics was proud to further expand the DxI 9000 Analyser menu with new infectious disease assays, including those for hepatitis and sexually transmitted infections.
For further information, Beckman Coulter Diagnostics can be contacted via email or through the website.